stockrow
Saturday 7 November 2026
Export ENLV’s income statement to Excel — free account
Enlivex Ltd.
ENLV Healthcare Biotechnology
- EPS
- +5,349.9%
- Free cash flow
- +35.9%
Quarter to June 2026, against a year earlier
1.27
0.00
0.00%
Follow ENLV
Alert me
| Older periods | Jun '25 | Sep '25 | Dec '25 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
6.41 | 6.43 | 193.24 | 119.39 |
Net Debt/EBITDA |
6.52 | 7.35 | 300.51 | 881.46 | |
Debt/Assets |
0.00% | 0.00% | 0.02% | 0.35% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.64 | 0.89 | 0.00 | 0.00 | |
Capex/Depreciation |
(0.08) | (0.26) | (0.11) | — | |
Interest Coverage |
2.54 | — | — | (3.12) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | — | |
Free Cash Flow per Share |
(12.12) | (19.85) | (13.83) | 0.00 | |
Cash per Share |
196.25 | 181.67 | 9,127.65 | 3,625.06 | |
Shareholders Equity per Share |
191.69 | 174.46 | 10,157.21 | 3,770.79 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
191.69 | 174.46 | 10,157.21 | 3,770.79 | |
Free Cash Flow |
(1.20) | (1.99) | (2.63) | — | |
Working Capital |
18.00 | 16.47 | 1,734.16 | 3,719.58 | |
Capital Expenditures |
(0.01) | (0.02) | (0.01) | — | |
Net Current Asset Value |
17.78 | 16.04 | 1,351.13 | 2,749.28 | |
| Other line items | |||||
Quick Ratio |
5.86 | 6.01 | 192.75 | 119.28 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(12.05) | (19.64) | (13.78) | 0.00 | |
Capex per Share |
(0.07) | (0.21) | (0.04) | 0.00 | |
Average Payables |
0.42 | 0.23 | 2.31 | 1.11 | |
Average Assets |
27.25 | 25.37 | 1,177.34 | 2,462.00 | |
Average Common Equity |
23.81 | 22.03 | 979.27 | 1,959.43 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | — |
Columns are period end dates · fundamentals updated 2 Nov 2026